A unique T cell subset described as CD4loCD40+ T cells (TCD40) in human type 1 diabetes.
about
Roles of tumor necrosis factor receptor associated factor 3 (TRAF3) and TRAF5 in immune cell functionsRecent advances in the genetics of autoimmune diseaseType 2 polarized immune response holds a major position in Epstein-Barr virus-related idiopathic thrombocytopenic purpura (EBV-ITP).Autoimmunity and the gutDefining a new biomarker for the autoimmune component of Multiple Sclerosis: Th40 cells.Recurrence of type 1 diabetes after simultaneous pancreas-kidney transplantation, despite immunosuppression, is associated with autoantibodies and pathogenic autoreactive CD4 T-cells.CD40 glycoforms and TNF-receptors 1 and 2 in the formation of CD40 receptor(s) in autoimmunityIsolation & characterization of Hoechst(low) CD45(negative) mouse lung mesenchymal stem cells.Pro-inflammatory T-lymphocytes rapidly infiltrate into the brain and contribute to neuronal injury following cardiac arrest and cardiopulmonary resuscitationA CD40-targeted peptide controls and reverses type 1 diabetes in NOD mice.Galectin-9 controls CD40 signaling through a Tim-3 independent mechanism and redirects the cytokine profile of pathogenic T cells in autoimmunity.The pathology of bleomycin-induced fibrosis is associated with loss of resident lung mesenchymal stem cells that regulate effector T-cell proliferation.Th40 cells (CD4+CD40+ Tcells) drive a more severe form of Experimental Autoimmune Encephalomyelitis than conventional CD4 T cells.High distribution of CD40 and TRAF2 in Th40 T cell rafts leads to preferential survival of this auto-aggressive population in autoimmunityDisruption of the homeostatic balance between autoaggressive (CD4+CD40+) and regulatory (CD4+CD25+FoxP3+) T cells promotes diabetes.T cells interact with T cells via CD40-CD154 to promote autoimmunity in type 1 diabetes.An alternative role for Foxp3 as an effector T cell regulator controlled through CD40CD40 interacts directly with RAG1 and RAG2 in autoaggressive T cells and Fas prevents CD40-induced RAG expression.CD40 and autoimmunity: the dark side of a great activator.Advances in our understanding of the pathophysiology of Type 1 diabetes: lessons from the NOD mouse.Recurrence of autoimmunity in pancreas transplant patients: research update.High Risk First Degree Relatives of Type 1 Diabetics: An Association with Increases in CXCR3(+) T Memory Cells Reflecting an Enhanced Activity of Th1 Autoimmune Response.Of the multiple mechanisms leading to type 1 diabetes, T cell receptor revision may play a prominent role (is type 1 diabetes more than a single disease?).Overlooked Mechanisms in Type 1 Diabetes Etiology: How Unique Costimulatory Molecules Contribute to DiabetogenesisCD40-mediated signalling influences trafficking, T-cell receptor expression, and T-cell pathogenesis, in the NOD model of type 1 diabetes.Role of CD40-dependent signal in induction of recombinase RAG-1 expression in peripheral T cells of patients with autoimmune diabetes mellitus.CD40 engagement of CD4+ CD40+ T cells in a neo-self antigen disease model ablates CTLA-4 expression and indirectly impacts tolerance
P2860
Q26853280-0642F79E-DCE4-4321-BDCC-0BD5ADA426BAQ28238782-EC58BD17-85CA-4CFD-B0B6-94A2D47A1718Q33397364-D0662871-3801-4C2B-A80E-7266E61FB912Q33676951-06692D67-33A7-47BC-BEA5-A1FC46E2F340Q33687644-16849D4C-2C9C-473A-89D6-AD74906321EAQ33750748-8B9A77D1-2820-46C3-B98B-D6868A73018FQ34054070-FF4580DF-4A00-42A3-B758-F3BE9127D9B0Q34069320-E92D6732-0D87-44BE-A080-8C304D1C6B0CQ34123502-644EED99-B61D-4A8E-833C-0A225A0F7281Q34283011-309F5CBA-FDBC-4FAD-8BA1-1CAC32CEC069Q34299740-1C506650-1A6C-4619-98F5-6324088B6479Q35878712-DEEF4CCF-A11E-4630-9653-7DE18423452DQ36278572-A7A1434C-DD61-4BBF-88F3-50E10B914BF2Q36572935-1C96B12C-90D8-4E2A-99FA-A2C438650AB1Q36803833-4BFEB5C2-1835-4F41-8C43-20BFCC23FA0DQ36971881-0535A106-15E3-4D3C-901B-292E102DB583Q37016800-D64F12EF-3F40-4CD6-9952-5BBC96AB27E6Q37282264-BFFD60D1-C77E-49E8-ADC0-BC2A805FF593Q37365433-B4C39E34-B02C-4DE1-9B0F-F8565C0E5597Q38135862-31170BAC-A70C-40CE-8242-8173382D4487Q38386317-64C548AD-DFB5-45D5-B46A-536F4749FCC0Q38652301-C483FD18-F1CA-4F1F-BAF8-D71CAFCA9BD9Q38857800-D2B92A99-551D-41EE-8ABD-52D05BB3F5B3Q41526144-251942A4-004F-4AC8-8B06-B1054367F546Q46360981-F8ED0349-CC7A-45D1-AD39-589713BFEAC0Q51556463-97B8EC09-D4F3-42B1-ADF5-9AB894CEE741Q56898286-A7FB44F2-3ED5-4451-859E-BF6AADEA027C
P2860
A unique T cell subset described as CD4loCD40+ T cells (TCD40) in human type 1 diabetes.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
A unique T cell subset described as CD4loCD40+ T cells (TCD40) in human type 1 diabetes.
@en
A unique T cell subset described as CD4loCD40+ T cells
@nl
type
label
A unique T cell subset described as CD4loCD40+ T cells (TCD40) in human type 1 diabetes.
@en
A unique T cell subset described as CD4loCD40+ T cells
@nl
prefLabel
A unique T cell subset described as CD4loCD40+ T cells (TCD40) in human type 1 diabetes.
@en
A unique T cell subset described as CD4loCD40+ T cells
@nl
P2093
P1433
P1476
A unique T cell subset described as CD4loCD40+ T cells (TCD40) in human type 1 diabetes
@en
P2093
Amy Putnam
Dan M Waid
David C Calverley
David H Wagner
Peter Gottlieb
Rebecca J Wagner
P304
P356
10.1016/J.CLIM.2007.05.003
P577
2007-06-08T00:00:00Z